Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Testicular function following chemotherapy.

S J Howell1, S M Shalet

  • 1Department of Endocrinology, Christie Hospital NHS Trust, Manchester, UK.

Human Reproduction Update
|July 31, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Polygenic risk scores to refine Breast cancer screening and prevention strategies.

Personalized medicine·2025
Same author

The smoke-free generation policy: policy analysis.

Perspectives in public health·2025
Same author

Capivasertib and fulvestrant for patients with hormone receptor-positive advanced breast cancer: characterization, time course, and management of frequent adverse events from the phase III CAPItello-291 study.

ESMO open·2024
Same author

Process, structural, and outcome quality indicators to support perioperative opioid stewardship: a rapid review.

Perioperative medicine (London, England)·2023
Same author

Tamoxifen evolution.

British journal of cancer·2023
Same author

The need for causal inference methods to answer causal questions.

Anaesthesia·2021
Same journal

Clinical outcomes and euploidy rates of embryos derived from zygotes with nonpronuclear (0PN) and monopronuclear (1PN) in IVF or ICSI cycles: a systematic review and meta-analysis.

Human reproduction update·2026
Same journal

Sperm mitochondrial DNA copy number: a marker of male fertility and reproductive success.

Human reproduction update·2026
Same journal

Embryo-derived extracellular vesicles and their potential as biomarkers for embryo quality during IVF: a systematic review.

Human reproduction update·2026
Same journal

Endometriosis and ovarian cancer: epidemiological evidence, molecular insights, and clinical decision-making.

Human reproduction update·2026
Same journal

Maternal genetic variants associated with aneuploid conception: a narrative review.

Human reproduction update·2026
Same journal

Iron overload disorders in adults: a comprehensive review of gonadal function, reproductive, and sexual health.

Human reproduction update·2026
See all related articles

Cytotoxic chemotherapy can cause long-term testicular dysfunction, impacting fertility. While sperm banking is the only proven preservation method, future options like hormonal therapy and germ cell cryopreservation are being explored.

Area of Science:

  • Oncology
  • Reproductive Medicine
  • Toxicology

Background:

  • Cytotoxic chemotherapy is a cornerstone in treating various malignancies.
  • Testicular dysfunction is a frequent long-term side effect of these treatments.
  • The extent of damage varies based on chemotherapy agents and dosage.

Purpose of the Study:

  • To review the impact of chemotherapy on testicular function.
  • To discuss the effects on germinal and Leydig cells.
  • To explore methods for preserving testicular function during cancer treatment.

Main Methods:

  • Review of existing literature on chemotherapy-induced gonadotoxicity.
  • Analysis of studies on specific chemotherapy regimens (e.g., procarbazine, cisplatin, carboplatin).

Related Experiment Videos

  • Examination of the effects on spermatogenesis and Leydig cell function.

    • Main Results:

    • Procarbazine regimens and high-dose chemotherapy for bone marrow transplant often lead to irreversible azoospermia or germinal epithelial failure.
    • Cisplatin and carboplatin regimens for testicular cancer typically cause temporary azoospermia/oligozoospermia, with 80% recovery by 5 years.
    • Mild Leydig cell impairment may occur but its clinical significance is uncertain.

    Conclusions:

    • Chemotherapy poses significant risks to male reproductive health, with varying degrees of severity.
    • Sperm banking is the current gold standard for fertility preservation.
    • Future research focuses on hormonal therapies and germ cell cryopreservation to enhance recovery and preservation.